COVID-19 & CancerFreeGuest Editorial COVID-19 and the cancer patient: A call to action for balancing cancer care and viral risk March 13, 2020Vol.46 No.11By Karen E. Knudsen and Roy A. Jensen
Conversation with The Cancer LetterCOVID-19 & CancerFree What to expect: Oncology’s response to coronavirus in Italy"It's like being in a war" March 11, 2020Vol.46 No.11By Alexandria Carolan
COVID-19 & CancerFree Coronavirus vs. oncology: Meeting cancellations, travel restrictions, fears about drug supply chain March 04, 2020Vol.46 No.10By Alexandria Carolan
FreeGuest Editorial Lung-MAP: A five-year recap on the first master protocol trial in cancer research February 21, 2020Vol.46 No.08By Roy S. Herbst, Lyudmila Bazhenova, Joel Neal and Saiama N. Waqar
Conversation with The Cancer LetterFree Thomas Lynch lists his areas of emphasis at the Hutch:Solid tumors, immuno-oncology, big data, microbial involvement January 31, 2020Vol.46 No.5By Paul Goldberg
Free The price of smoking for a lifetime is lowest in the South, highest in the NortheastHere are the numbers January 24, 2020Vol.46 No.04By Alexandria Carolan
Conversation with The Cancer LetterFree Robert Winn holds forth on big data, bench-to-community research—and being the only African American director of an NCI-designated cancer center January 17, 2020Vol.46 No.03By Paul Goldberg
FreeGuest Editorial Immunotherapy, precision medicine in lung cancer drive sharp decline in cancer mortality overall January 08, 2020Vol.46 No.02By Otis W. Brawley
